280 related articles for article (PubMed ID: 35761386)
1. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M
J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.
Fei D; Yuan H; Zhao M; Zhao D
Cell Biol Int; 2022 Nov; 46(11):1937-1946. PubMed ID: 36041209
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
8. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
9. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
13. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
14. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
Xue Y; Liu H; Nie G; Ren X
Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889
[TBL] [Abstract][Full Text] [Related]
15. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
16. FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.
Gong X; Huang M; Chen L; Zeng H
Acta Neurol Belg; 2023 Aug; 123(4):1453-1464. PubMed ID: 37074635
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
18. LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2.
Yang Z; Liu Z; Lu W; Guo H; Chen J; Zhang Y
Biol Direct; 2023 Nov; 18(1):74. PubMed ID: 37957698
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]